Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $7.07 | N/A |
Market Cap | $465.39M | N/A |
Shares Outstanding | 65.87M | N/A |
Employees | 1.40K | N/A |